210 related articles for article (PubMed ID: 26163879)
1. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
[TBL] [Abstract][Full Text] [Related]
2. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
Zheng Z; Liu S; Wang C; Han X
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
[TBL] [Abstract][Full Text] [Related]
3. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
[TBL] [Abstract][Full Text] [Related]
5. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk.
Zhu Z; Gao X; He Y; Zhao H; Yu Q; Jiang D; Zhang P; Ma X; Huang H; Dong D; Wan J; Gu Z; Jiang X; Yu L; Gao Y
Cancer Res; 2012 Dec; 72(23):6163-72. PubMed ID: 23026137
[TBL] [Abstract][Full Text] [Related]
6. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
Shen Z; She Q
Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
[TBL] [Abstract][Full Text] [Related]
7. An indel polymorphism within pre-miR3131 confers risk for hepatocellular carcinoma.
Wang C; Li L; Yin Z; Zhang Q; Zhao H; Tao R; Wang S; Hu S; He Y; Wang D; Li C; Zhang S; Xu J; Jiang X; Zhu S; Gao Y
Carcinogenesis; 2017 Feb; 38(2):168-176. PubMed ID: 28034876
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.
Chang L; Li C; Lan T; Wu L; Yuan Y; Liu Q; Liu Z
Mol Med Rep; 2016 Feb; 13(2):1541-50. PubMed ID: 26707238
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
[TBL] [Abstract][Full Text] [Related]
10. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population.
Liu CH; Lu YL; Huang HT; Wang CF; Luo HC; Wei GJ; Lei M; Tan T; Wang Y; Huang YY; Wei YS; Lan Y
J Cell Mol Med; 2021 Apr; 25(7):3548-3559. PubMed ID: 33728802
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.
Sha Z; Zhang P
Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
13. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
Li Q; Ma G; Sun S; Xu Y; Wang B
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
[TBL] [Abstract][Full Text] [Related]
15. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
[TBL] [Abstract][Full Text] [Related]
16. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
Xiong XD; Fang JH; Qiu FE; Zhao J; Cheng J; Yuan Y; Li SP; Zhuang SM
Mutat Res; 2008 Aug; 643(1-2):70-4. PubMed ID: 18640135
[TBL] [Abstract][Full Text] [Related]
17. A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population.
Yu Q; Zhou C; Wang J; Chen L; Zheng S; Zhang J
DNA Cell Biol; 2013 Aug; 32(8):451-7. PubMed ID: 23777424
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variants of
Deng F; Zhu P; Liao C; Li S; Hu X; Wang Y; Wu Z; Huang S; Zhong W; Zhao B; Ma G; Li Y
Biomed Res Int; 2021; 2021():6634253. PubMed ID: 33937403
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer.
Wang Y; Wu S; Yang X; Li X; Chen R
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902880
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]